JNJ Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Johnson & Johnson. Stock Analysis JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,100 full-time employees. The firm's primary focus is products related to human health and well-being. The firm operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolism. Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, cardiovascular, and vision fields. These products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eyecare professionals, and clinics.
Read More JNJ Chart
Johnson & Johnson vs S&P 500 Comparative Returns
Analysis of JNJ stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Johnson & Johns... (JNJ...) 7.63%
- S&P 500 -4.27%
Johnson & Johnson Outperformed S&P 500 by 11.90%
1Y Performance
- Johnson & Johns... (JNJ...) 4.5%
- S&P 500 8.86%
Johnson & Johnson Underperformed S&P 500 by 4.36%
3Y Performance
- Johnson & Johns... (JNJ...) -12.22%
- S&P 500 37.21%
Johnson & Johnson Underperformed S&P 500 by 49.43%
5Y Performance
- Johnson & Johns... (JNJ...) 4.68%
- S&P 500 92.3%
Johnson & Johnson Underperformed S&P 500 by 87.62%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$155.82Volume
7.60MP/E Ratio (TTM)
26.9952 Week Range
Market Cap
393.50BAvg. Volume
8.36MDividend Yield
3.11%Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenue per Share (TTM) | - | 31.37 | 29.95 | 35.38 | - |
EBIT per Share (TTM) | - | 7.79 | 7.85 | 10.07 | - |
Earnings per Share (EPS) (TTM) | 5.59 | 7.93 | 6.83 | 13.88 | - |
Dividend per Share (TTM) | - | 3.98 | 4.2 | 4.47 | - |
EPS Forward | - | 5.51 | 7.81 | 6.73 | 5.79 |
Super Investors
View All ➜Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Tweedy Browne
% Portfolio:
10.53 Recent Activity:-4.06%
Yacktman Asset Management
% Portfolio:
2.34 Recent Activity:-1.89%
Robert Olstein
% Portfolio:
1.65 Recent Activity:6.56%
Tom Gayner
% Portfolio:
0.78 Recent Activity:-

Community-Curated Collections ( With JNJ )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
Dow Jones Industrial Average Index
By Dilnoza Mirsaidova
208 Followers
Halal Divident Stock
By Monirul Islam
92 Followers
Halal High Dividend Stocks
By Mo Omari
65 Followers
Biotech & Drugs
By Bunyod Rayim
44 Followers
US Mega Cap Stocks
By Dilnoza Mirsaidova
39 Followers
Top 10 Halal Dividend Growers in the US Market
By Investment Alchemist
35 Followers
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.